ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

NSABP Executive Committee Drops Suit Against Pitt

February 10, 1995

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978

NIH News: Varmus Presents “Modest Proposal for a Simpler NIH”

August 6, 1999

NIH announces The Cancer Genome Atlas, new name for human cancer genome project.

December 16, 2005